| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/12/2006 | CN1250204C Physical stable spraying gel composition |
| 04/12/2006 | CN1250193C Oil-in-water type cosmetics |
| 04/12/2006 | CN1250121C Compound tobacco addict controlling plaster and its preparation method |
| 04/11/2006 | USRE39061 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 04/11/2006 | US7026508 Succinate salt of O-desmethyl-venlafaxine |
| 04/11/2006 | US7026471 Purification method of hydroxypropylmethyl cellulose phthalate |
| 04/11/2006 | US7026452 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 04/11/2006 | US7026431 Sustained release ionic conjugate |
| 04/11/2006 | US7026361 Dispersion stability; forming protective colloid; bioavailability; hypotensive agents, oral diseases |
| 04/11/2006 | US7026360 Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
| 04/11/2006 | US7026359 e.g., tridecafluoro-4,4-dimethyl-1-heptene trimer or 1H, 1H, 2H-perfluoro-1-octane trimer; causes little or no damage to the retina even when used over a long period. |
| 04/11/2006 | US7026338 Pharmaceutical nitrones |
| 04/11/2006 | US7026337 Gel formulations of hydroxypyridone derivatives, which contain solvents and hydrophilic gel-forming agents make possible a high release of the active compound |
| 04/11/2006 | US7026303 xylose or arabinose surrounded by a hydrophobic layer and/or a hydrophilic layer, used for normalizing bowel function, inducing laxation, providing dietary fiber, and/or reducing serum cholesterol levels |
| 04/11/2006 | US7026290 surfactant; an amphiphilic solvent comprising a lower alkyl hydroxy alkanoic acid ester or an N-alkyl pyrrolidone; and a cyclosporin; capable of forming particles of a size of less than about 100 nm upon contact with an aqueous solution |
| 04/11/2006 | US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/11/2006 | US7026160 Oral bacteriotherapy compositions and methods |
| 04/11/2006 | US7025993 Herbal composition PHY906 and its use in chemotherapy |
| 04/11/2006 | US7025992 Administering lipophilic drug through mucous membranes |
| 04/11/2006 | US7025991 Nanoparticle drug delivery |
| 04/11/2006 | US7025990 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 04/11/2006 | US7025989 At least three delayed release dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours. |
| 04/11/2006 | US7025988 Forming dehydration-rehydration vesicles with lipophilic drug paclitaxel, dissolving sugar into the aqueous suspension; drug delivery of antitumor treatment |
| 04/11/2006 | US7025987 Delivery system for nucleic acids |
| 04/11/2006 | US7025986 High molecular weight polyethylene; dentistry |
| 04/11/2006 | US7025984 Controlling appetite; using ethyl oleate |
| 04/11/2006 | US7025983 Water soluble film forming polymer |
| 04/11/2006 | US7025982 Making an implant for long-term implantation by modifying the surface to form a hydrophilic adhesion-promoting surface, coating with an alginate solution and gelling the alginate with Group 2a cations; pacemakers, stents, catheters |
| 04/11/2006 | US7025979 Male contraceptive formulation comprising norethisterone |
| 04/11/2006 | US7025975 Galenical formulations |
| 04/11/2006 | US7025974 Prevention micobiocide infections; parasiticides; disposable products |
| 04/11/2006 | US7025973 Acid cosmetic, dermatological and pharmaceutical agents |
| 04/11/2006 | US7025965 Method of use and dosage composition of bluegreen algae extract for inflammation in animals |
| 04/11/2006 | US7025911 Manufacturing method for oral quick-dissolving seamless capsule |
| 04/11/2006 | US7025869 Nitric oxide delivery system |
| 04/11/2006 | US7025760 Method and system for non-vascular sensor implantation |
| 04/11/2006 | US7025743 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 04/11/2006 | US7025290 Generation of therapeutic microfoam |
| 04/11/2006 | CA2372710C Laminates containing an active substance for transdermal systems |
| 04/11/2006 | CA2358829C Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/11/2006 | CA2335582C Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/11/2006 | CA2317549C Composition for enhancing transport through lipid-containing membranes, and uses thereof |
| 04/11/2006 | CA2200952C Novel compositions comprising quaternary ammonium compounds and neutral lipids for the introduction of polyanionic materials into cells |
| 04/11/2006 | CA2178632C Pharmaceutical compositions containing hiv protease inhibitors |
| 04/11/2006 | CA2165783C Soft gelatin capsule shell compositions |
| 04/07/2006 | CA2522152A1 Transdermal and transmucosal preparations |
| 04/06/2006 | WO2006037116A2 Semi-solid delivery vehicle and pharmaceutical compositions |
| 04/06/2006 | WO2006037113A2 Multifunctional supramolecular hydrogels as biomaterials |
| 04/06/2006 | WO2006037089A2 Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| 04/06/2006 | WO2006037080A2 Uv cured gel and method of making |
| 04/06/2006 | WO2006037070A2 Stabilization of alum-adjuvanted immunologically active agents |
| 04/06/2006 | WO2006036984A2 Stand-alone film and methods for making the same |
| 04/06/2006 | WO2006036969A2 Formation of barrier layer |
| 04/06/2006 | WO2006036964A2 Barrier layer |
| 04/06/2006 | WO2006036899A2 Transdermal systems for the delivery of estrogens and progestins |
| 04/06/2006 | WO2006036624A2 Lipid stabilized formulations |
| 04/06/2006 | WO2006036614A2 A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
| 04/06/2006 | WO2006036581A2 Silver-containing antimicrobial fabric |
| 04/06/2006 | WO2006036417A1 Mucosal or cutaneous medicinal or hygiene system |
| 04/06/2006 | WO2006036280A1 Ocular implant made by a double extrusion process |
| 04/06/2006 | WO2006036007A2 Modified-release preparation |
| 04/06/2006 | WO2006035977A1 Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid |
| 04/06/2006 | WO2006035939A1 Immune stimulating oligonucleotide and use thereof in pharmaceutical |
| 04/06/2006 | WO2006035923A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 04/06/2006 | WO2006035900A1 Coenzyme q10-containing emulsified composition |
| 04/06/2006 | WO2006035797A1 Nonanimal-origin soft capsule coating and soft capsule having the same |
| 04/06/2006 | WO2006035760A1 Drug for treating skin disease |
| 04/06/2006 | WO2006035418A2 Microcapsules comprising a methylxanthine and a corticosteroid |
| 04/06/2006 | WO2006035417A2 Dihydropyrimidine microcapsule - formulations |
| 04/06/2006 | WO2006035416A2 Minicapsule formulations |
| 04/06/2006 | WO2006035414A2 Carbidopa and levodopa dispersible tablets |
| 04/06/2006 | WO2006035313A1 Solid unit dosage forms of 5-ht1 agonist |
| 04/06/2006 | WO2006034661A1 A method for producing oral solid dosage form and oral solid dosage form prepared thereby |
| 04/06/2006 | WO2005123138A9 Pharmaceutical pellet compositions for controlled release |
| 04/06/2006 | WO2005120578A9 Biodegradable drug-polymer delivery system |
| 04/06/2006 | WO2005120454A3 Composite material for use as protein carrier |
| 04/06/2006 | WO2005120158A3 Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same |
| 04/06/2006 | WO2005110375A8 Nutritional supplement for treatment of ocular diseases |
| 04/06/2006 | WO2005110360A3 Compositions for injection |
| 04/06/2006 | WO2005110022A3 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 04/06/2006 | WO2005107701A3 Remote control release of material encapsulated in polyelectrolyte multilayer microcapsules |
| 04/06/2006 | WO2005102268A3 Cholinesterase inhibitors in liposomes and their production and use |
| 04/06/2006 | WO2005079755A3 Interleukin-13 antagonist powders, spray-dried particles, and methods |
| 04/06/2006 | WO2005074982A3 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 04/06/2006 | WO2005074900A3 NOVEL COMBINATION OF ANTICHOLINERGIC AND β MIMETICS FOR THE TREATMENT OF RESPIRATORY DISEASES |
| 04/06/2006 | WO2005072079A3 Drug coating providing high drug loading and methods for providing the same |
| 04/06/2006 | WO2005044221A3 Solid active ingredient formulation |
| 04/06/2006 | WO2005041937A3 Controlled release sterile injectable aripiprazole formulation and method |
| 04/06/2006 | WO2005041931A3 Pharmaceutical aerosol compositions |
| 04/06/2006 | WO2005039527A3 Extended release pharmaceutical dosage form |
| 04/06/2006 | US20060074404 Implantable drug delivery system responsive to intra-cardiac pressure |
| 04/06/2006 | US20060074381 Medical device initialization method & system |
| 04/06/2006 | US20060074377 Microprojection array immunization patch and method |
| 04/06/2006 | US20060074053 Ophthalmic solution containing quinolone antimicrobial compound |
| 04/06/2006 | US20060074036 Agents for gene therapy of cerebrovascular disorders |
| 04/06/2006 | US20060074027 Microcapsules of luteinizing hormone releasing hormone agonists; glycolic acid-lactic acid copolymers; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, precocious puberty, dymenorrhea or breast cancer, or inhibiting conception |
| 04/06/2006 | US20060074025 Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability |
| 04/06/2006 | US20060074013 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 04/06/2006 | US20060074011 pH above 5.5 may be delivered to a subject with reduced pain |
| 04/06/2006 | US20060073333 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |